Skip To The Main Content

News & Events

Matter Highlights Go Back

Firm Represents Underwriters in US$152.7 Million NASDAQ IPO of iKang Healthcare Group, Inc.

04.17.14

The Hong Kong and Beijing offices of the Firm represented the underwriters, led by Merrill Lynch, Pierce, Fenner & Smith Incorporated and UBS Securities LLC in connection with the initial public offering and listing on the Nasdaq Global Market of American depositary shares (“ADSs”) of iKang Guobin Healthcare Group, Inc. (“iKang”). The offering of 10,904,846 ADSs, every two of which represents one (1) Class A Common Shares, raised an aggregate of US$152.7 million.

iKang is the largest provider of private preventive healthcare services market in China. Through iKang’s integrated service platform and network of medical centers and third-party service provider facilities in China, iKang provides comprehensive and high quality preventive healthcare solutions, including a wide range of medical examinations services and value-added services, including disease screening and other services. Its ADSs are traded on the Nasdaq Global Market under the ticker symbol “KANG”.

The Simpson Thacher team for the transaction included Chris Lin, Daniel Fertig and Asher Hsu (Corporate); Jennie Getsin (FINRA); and Vanessa Grieve (Tax).